Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05064722 · ClinicalTrials.gov registry record · NA
Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve
A NA study, sponsored by GI Windows.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05064722 is a NA study that has completed, run by GI Windows. The registered enrollment target is 10 participants.
The verdict
NCT05064722, a NA study, has completed, sponsored by GI Windows.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a dual-path duodenal-ileal (D-I) diversion either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior sleeve gastrectomy who experience inadequate weight loss (i.e., SNAP-PS procedure). Additionally, the study is designed to evaluate the potential of the SNAP-S/SNAP-PS procedures to induce weight loss and to improve metabolic comorbidities in obese subjects.
Interventions
- DEVICE Self Forming Magnets (SFM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-11-08 |
| Est. Completion | 2024-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05064722
The ClinicalTrials.gov registry entry for NCT05064722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GI Windows, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self Forming Magnets (SFM) is the first listed.
NCT05064722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05064722 about?
NCT05064722 is a clinical study titled "Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve". The objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a dual-path duodenal-ileal (D-I) diversion either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior sleeve gastr...
What is the current status of trial NCT05064722?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-11-08. Estimated completion is 2024-10-09.
What interventions are being tested in trial NCT05064722?
The interventions under investigation include: Self Forming Magnets (SFM) (DEVICE).
Who is sponsoring clinical trial NCT05064722?
This trial is sponsored by GI Windows, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.